Credit Agricole S A Eli Lilly & CO Put Options Transaction History

Credit Agricole S A

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2025 Nov 14, 2025	BUY	$625.65 - $812.69 $29.1 Million - $37.8 Million	46,500 Added 143.08%	79,000 $60.3 Million
Q1 2025 May 14, 2025	BUY	$725.72 - $929.72 $5.81 Million - $7.44 Million	8,000 Added 32.65%	32,500 $26.8 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $5.45 Million - $6.99 Million	7,500 Added 44.12%	24,500 $18.9 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $2.7 Million - $3.36 Million	3,500 Added 25.93%	17,000 $15.1 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $7.99 Million - $10.7 Million	13,500 New	13,500 $10.5 Million

Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $3.88 Million - $4.56 Million	12,500 New	12,500 $4.29 Million

4,501

753M

14.9M

16.9M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $971B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.